Skip to main content
Erschienen in:

03.08.2020 | Original Article

The development of extraintestinal manifestation and related risk factors in Crohn’s patients

verfasst von: Yusuf Kayar, Ramazan Dertli, Sevki Konur, Mehmet Agin, Bulent Baran, Asli Ciftcibasi Ormeci, Filiz Akyuz, Kadir Demir, Fatih Besisik, Sabahattin Kaymakoglu

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Crohn’s disease (CD) primarily involves gastrointestinal tract; however, it can present with extraintestinal manifestations (EIMs), which leads to significant morbidity. Frequency of EIMs and associated risk factors vary due to genetic and environmental differences in studies.

Aim

To examine the frequency and risk factors associated with EIMs in CD.

Method

Patients with CD under follow-up from March 1986 to October 2011 were included in this study. Demographics, type of EIMs, autoimmune diseases, and clinical features of CD were recorded. Frequency of EIMs and associated risk factors were analyzed.

Results

Three hundred thirty-six patients with CD were included in the study (mean follow-up duration 7.54 years). 55.4% (n: 186) were male and the mean age at diagnosis of CD was 30.6 years (range, 10.3–68.2 years). At least one EIM was detected in 47.3% and multiple EIMs in 22.9% of the cohort. Oral, joint, and skin involvements (32.4%, 24.7%, 9.2%, respectively) were the most common EIMs. Female gender (OR: 2.19, 95% CI: 1.34–3.58, p = 0.001), corticosteroid usage (OR: 2.32, 95% CI: 1.28–4.22, p = 0.007), and positive family history (OR: 5.61, 95% CI: 1.95–3.58, p = 0.001) were independent risk factors for EIM development. Colonic involvement (OR: 3.93, 95% CI: 1.59–9.68, p = 0.003), no surgical operation (OR: 2.31, 95% CI: 1.14–4.68, p = 0.020), and corticosteroid usage (OR: 2.85, 95% CI: 1.07–7.61, p = 0.037) were independent risk factors for multiple EIM development.

Conclusion

Although the immunological and clinical associations between EIMs and CD cannot be fully elucidated, identifying specific relationships of immune-mediated diseases will help to better understand CD pathogenesis.
Literatur
1.
Zurück zum Zitat Acosta MB, Domınguez-Munoz JE, Nunez-Pardo MC et al (2007) Relationship between clinical features of Crohn’s disease and the risk of developing extraintestinal manifestations. Eur J Gastroenterol Hepatol 19:73–78CrossRef Acosta MB, Domınguez-Munoz JE, Nunez-Pardo MC et al (2007) Relationship between clinical features of Crohn’s disease and the risk of developing extraintestinal manifestations. Eur J Gastroenterol Hepatol 19:73–78CrossRef
2.
Zurück zum Zitat Kayar Y, Baran B, Ormeci AC et al (2019) Risk factors associated with progression to intestinal complications of Crohn disease. Chin Med J 132(20):2423–2429CrossRef Kayar Y, Baran B, Ormeci AC et al (2019) Risk factors associated with progression to intestinal complications of Crohn disease. Chin Med J 132(20):2423–2429CrossRef
3.
Zurück zum Zitat Rothfuss KS, Stange EF, Herrlinger KR (2006) Extraintestinal manifestations and complications in inflammatory bowel diseases. World J Gastroenterol 12(30):4819–4831CrossRef Rothfuss KS, Stange EF, Herrlinger KR (2006) Extraintestinal manifestations and complications in inflammatory bowel diseases. World J Gastroenterol 12(30):4819–4831CrossRef
4.
Zurück zum Zitat Lakatos PL, Szalay F, Tulassay Z et al (2005) Clinical presentation of Crohn’s disease. Association between familial disease, smoking, disease phenotype, extraintestinal manifestations and need for surgery. Hepato-Gastroenterol 52:817–822 Lakatos PL, Szalay F, Tulassay Z et al (2005) Clinical presentation of Crohn’s disease. Association between familial disease, smoking, disease phenotype, extraintestinal manifestations and need for surgery. Hepato-Gastroenterol 52:817–822
5.
Zurück zum Zitat Lakatos L, Pandur T, David G et al (2003) Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol 9(10):2300–2307CrossRef Lakatos L, Pandur T, David G et al (2003) Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol 9(10):2300–2307CrossRef
6.
Zurück zum Zitat Bernstein CN, Blanchard JF, Rawsthorne P, Yu N (2001) The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 96:1116–1122CrossRef Bernstein CN, Blanchard JF, Rawsthorne P, Yu N (2001) The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 96:1116–1122CrossRef
7.
Zurück zum Zitat Vavricka SR, Brun L, Ballabeni P et al (2011) Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 106:110–119CrossRef Vavricka SR, Brun L, Ballabeni P et al (2011) Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 106:110–119CrossRef
8.
Zurück zum Zitat Hwangbo Y, Kim HJ, Park JS et al (2010) Sacroiliitis is common in Crohn’s disease patients with perianal or upper gastrointestinal involvement. Gut Liver 4:338–344CrossRef Hwangbo Y, Kim HJ, Park JS et al (2010) Sacroiliitis is common in Crohn’s disease patients with perianal or upper gastrointestinal involvement. Gut Liver 4:338–344CrossRef
9.
Zurück zum Zitat Repiso A, Alcántara M, Muñoz-Rosas C et al (2006) Extraintestinal manifestations of Crohn’s disease: prevalence and related factors. Rev Esp Enferm Dig 98(7):510–517CrossRef Repiso A, Alcántara M, Muñoz-Rosas C et al (2006) Extraintestinal manifestations of Crohn’s disease: prevalence and related factors. Rev Esp Enferm Dig 98(7):510–517CrossRef
10.
Zurück zum Zitat Vavricka SR, Schoepfer A, Scharl M et al (2015) Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 21(8):1982–1992CrossRef Vavricka SR, Schoepfer A, Scharl M et al (2015) Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 21(8):1982–1992CrossRef
11.
Zurück zum Zitat Veloso FT (2011) Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome? World J Gastroenterol 17(22):2702–2707CrossRef Veloso FT (2011) Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome? World J Gastroenterol 17(22):2702–2707CrossRef
12.
Zurück zum Zitat Isene R, Bernklev T, Høie O et al (2015) Extraintestinal manifestations in Crohn’s disease and ulcerative colitis: results from a prospective, population-based European inception cohort. Scand J Gastroenterol 50(3):300–305CrossRef Isene R, Bernklev T, Høie O et al (2015) Extraintestinal manifestations in Crohn’s disease and ulcerative colitis: results from a prospective, population-based European inception cohort. Scand J Gastroenterol 50(3):300–305CrossRef
13.
Zurück zum Zitat Silverberg MS, Atsangi J, Ahmad T et al (2005) Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19:5–36CrossRef Silverberg MS, Atsangi J, Ahmad T et al (2005) Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19:5–36CrossRef
14.
Zurück zum Zitat Gasche C, Scholmerich J, Brynskov J et al (2000) A simple classification of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 6:8–15CrossRef Gasche C, Scholmerich J, Brynskov J et al (2000) A simple classification of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 6:8–15CrossRef
15.
Zurück zum Zitat Witte J, Shivananda S, Lennard-Jones JE et al (2000) Disease outcome in inflammatory bowel disease: mortality, morbidity and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Scand J Gastroenterol 35:1272–1277CrossRef Witte J, Shivananda S, Lennard-Jones JE et al (2000) Disease outcome in inflammatory bowel disease: mortality, morbidity and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Scand J Gastroenterol 35:1272–1277CrossRef
16.
Zurück zum Zitat Salvarani C, Vlachonikolis IG, van der Heijde DM et al (2001) Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol 36:1307–1313CrossRef Salvarani C, Vlachonikolis IG, van der Heijde DM et al (2001) Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol 36:1307–1313CrossRef
17.
Zurück zum Zitat Rankin GB, Watts HD, Melnyk CS, Kelley ML Jr (1979) National cooperative Crohn’s disease study: extraintestinal manifestations and perianal complications. Gastroenterology 77:914–920CrossRef Rankin GB, Watts HD, Melnyk CS, Kelley ML Jr (1979) National cooperative Crohn’s disease study: extraintestinal manifestations and perianal complications. Gastroenterology 77:914–920CrossRef
18.
Zurück zum Zitat Nguyen GC, Torres EA, Regueiro M et al (2006) Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic whites: characterization of a large North American cohort. Am J Gastroenterol 101:1012–1023CrossRef Nguyen GC, Torres EA, Regueiro M et al (2006) Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic whites: characterization of a large North American cohort. Am J Gastroenterol 101:1012–1023CrossRef
19.
Zurück zum Zitat White JM, O’Connor S, Winter HS et al (2004) Different patterns of inflammatory bowel disease between African-American children and other racial/ethnic groups in a large, multicentre registry of 1640 children. Gastroenterology 126:457 White JM, O’Connor S, Winter HS et al (2004) Different patterns of inflammatory bowel disease between African-American children and other racial/ethnic groups in a large, multicentre registry of 1640 children. Gastroenterology 126:457
20.
Zurück zum Zitat Yüksel I, Basar O, Ataseven H et al (2009) Mucocutaneous manifestations in inflammatory bowel disease. Infl amm Bowel Dis 15:546–550CrossRef Yüksel I, Basar O, Ataseven H et al (2009) Mucocutaneous manifestations in inflammatory bowel disease. Infl amm Bowel Dis 15:546–550CrossRef
21.
Zurück zum Zitat Greuter T, Vavricka SR (2009) Extraintestinal manifestations in inflammatory bowel disease epidemiology, genetics, and pathogenesis. Expert Rev Gastroenterol Hepatol 13(4):307–317CrossRef Greuter T, Vavricka SR (2009) Extraintestinal manifestations in inflammatory bowel disease epidemiology, genetics, and pathogenesis. Expert Rev Gastroenterol Hepatol 13(4):307–317CrossRef
22.
Zurück zum Zitat Danese S, Semeraro S, Papa A et al (2005) Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol 11(46):7227–7236CrossRef Danese S, Semeraro S, Papa A et al (2005) Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol 11(46):7227–7236CrossRef
23.
Zurück zum Zitat Levine JS, Burakoff R (2011) Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N.Y) 7(4):235–241 Levine JS, Burakoff R (2011) Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N.Y) 7(4):235–241
24.
Zurück zum Zitat Jose FA, Heyman MB (2008) Extraintestinal manifestations of inflammatory bowel disease. J Pediatr Gastroenterol Nutr 46:124–133CrossRef Jose FA, Heyman MB (2008) Extraintestinal manifestations of inflammatory bowel disease. J Pediatr Gastroenterol Nutr 46:124–133CrossRef
25.
Zurück zum Zitat Greenstein AJ, Janowitz HD, Sachar DB (1976) The extra-intestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients. Medicine 55:401–412CrossRef Greenstein AJ, Janowitz HD, Sachar DB (1976) The extra-intestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients. Medicine 55:401–412CrossRef
26.
Zurück zum Zitat Nemetz A, Molnar T, Zagoni T et al (2003) Phenotypes defined by the ‘Vienna Classification’ in 100 Hungarian patients with Crohn’s disease. Rev Esp Enferm Dig 95:527–538 Nemetz A, Molnar T, Zagoni T et al (2003) Phenotypes defined by the ‘Vienna Classification’ in 100 Hungarian patients with Crohn’s disease. Rev Esp Enferm Dig 95:527–538
27.
Zurück zum Zitat Farmer RG, Whelan G, Fazio VW (1985) Long-term follow-up of patients with Crohn’s disease. Gastroenterology 88(6):1818–1825CrossRef Farmer RG, Whelan G, Fazio VW (1985) Long-term follow-up of patients with Crohn’s disease. Gastroenterology 88(6):1818–1825CrossRef
28.
Zurück zum Zitat Taleban S, Li D, Targan SR et al (2016) Ocular manifestations in inflammatory bowel disease are associated with other extra-intestinal manifestations, gender, and genes implicated in other immune-related traits. J Crohns Colitis 10(1):43–49CrossRef Taleban S, Li D, Targan SR et al (2016) Ocular manifestations in inflammatory bowel disease are associated with other extra-intestinal manifestations, gender, and genes implicated in other immune-related traits. J Crohns Colitis 10(1):43–49CrossRef
29.
Zurück zum Zitat Hedin CRH, Vavricka SR, Stagg A et al (2018) The pathogenesis of extraintestinal manifestations: implications for IBD research, diagnosis and therapy. J Crohns Colitis 13(5):541–554CrossRef Hedin CRH, Vavricka SR, Stagg A et al (2018) The pathogenesis of extraintestinal manifestations: implications for IBD research, diagnosis and therapy. J Crohns Colitis 13(5):541–554CrossRef
30.
Zurück zum Zitat Satsangi J, Grootscholten C, Holt H, Jewell DP (1996) Clinical patterns of familial inflammatory bowel disease. Gut 38(5):738–741CrossRef Satsangi J, Grootscholten C, Holt H, Jewell DP (1996) Clinical patterns of familial inflammatory bowel disease. Gut 38(5):738–741CrossRef
31.
Zurück zum Zitat Larsen S, Bendtzen K, Nielsen OH (2010) Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management. Ann Med 42(2):97–114CrossRef Larsen S, Bendtzen K, Nielsen OH (2010) Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management. Ann Med 42(2):97–114CrossRef
32.
Zurück zum Zitat Prideaux L, Kamm MA, De Cruz PP et al (2012) Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol 27(8):1266–1280CrossRef Prideaux L, Kamm MA, De Cruz PP et al (2012) Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol 27(8):1266–1280CrossRef
33.
Zurück zum Zitat Hou JK, El-Serag H, Thirumurthi S (2009) Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review. Am J Gastroenterol 104(8):2100–2109CrossRef Hou JK, El-Serag H, Thirumurthi S (2009) Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review. Am J Gastroenterol 104(8):2100–2109CrossRef
34.
Zurück zum Zitat Vavricka SR, Gubler M, Gantenbein C et al (2017) Anti-TNF treatment for extraintestinal manifestations of inflammatory bowel disease in the Swiss IBD cohort study. Inflamm Bowel Dis 23(7):1174–1181CrossRef Vavricka SR, Gubler M, Gantenbein C et al (2017) Anti-TNF treatment for extraintestinal manifestations of inflammatory bowel disease in the Swiss IBD cohort study. Inflamm Bowel Dis 23(7):1174–1181CrossRef
35.
Zurück zum Zitat Cusick MF, Libbey JE, Fujinami RS (2012) Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol 42(1):102–111CrossRef Cusick MF, Libbey JE, Fujinami RS (2012) Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol 42(1):102–111CrossRef
Metadaten
Titel
The development of extraintestinal manifestation and related risk factors in Crohn’s patients
verfasst von
Yusuf Kayar
Ramazan Dertli
Sevki Konur
Mehmet Agin
Bulent Baran
Asli Ciftcibasi Ormeci
Filiz Akyuz
Kadir Demir
Fatih Besisik
Sabahattin Kaymakoglu
Publikationsdatum
03.08.2020
Verlag
Springer International Publishing
Erschienen in
Irish Journal of Medical Science (1971 -) / Ausgabe 2/2021
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-020-02326-z

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Adjuvanter PD-L1-Hemmer verhindert Rezidive bei Hochrisiko-Urothelkarzinom

Sind Menschen mit muskelinvasivem Urothelkarzinom für die neoadjuvante platinbasierte Therapie nicht geeignet oder sprechen sie darauf nicht gut an, ist Pembrolizumab eine adjuvante Alternative: Die krankheitsfreie Lebenszeit wird dadurch mehr als verdoppelt.

Duale Checkpointhemmung gegen Melanome verlängert langfristig das Leben

Im Vergleich zu den Überlebenschancen vor der Einführung von Immuncheckpointhemmern (ICI) ist der Fortschritt durch eine ICI-Kombination mit unterschiedlichen Tagets bei fortgeschrittenem Melanom erstaunlich. Das belegen die finalen Ergebnisse der CheckMate-067-Studie und geben Betroffenen "Hoffnung auf Heilung".

Knochenmarktransplantat als Chance für ältere AML-Patienten

Lange Zeit ist die Transplantation von hämatopoetischen Stammzellen nur bei jüngeren Patienten mit akuter myeloischer Leukämie praktiziert worden. Inzwischen profitieren auch Ältere davon. Ergebnisse einer Studie unterstützen dieses Vorgehen.

Nierenzellkarzinom: Kein Nachteil durch subkutan appliziertes Nivolumab

Die subkutane Applikation von Nivolumab ist nach Daten einer Phase-3-Studie ähnlich gut wirksam wie die intravenöse: Die Pharmakokinetik ist vergleichbar, die objektive Response war in der Studie sogar leicht besser als in der Gruppe mit Infusionen.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.